Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Allergies Clinical Trials
Allergies clinical trials are recruiting across 14 cities. Here are the cities with the most active studies:
Allergies Trial Phases
5 research organizations are sponsoring allergies trials.
About Allergies
Allergies occur when the immune system reacts to substances like pollen, food, or pet dander that are typically harmless. They are among the most common chronic conditions worldwide. Treatment includes avoidance, antihistamines, nasal corticosteroids, and allergen immunotherapy.
Clinical trials are advancing new treatments for allergies. Currently, 5 studies are recruiting a combined 13,268 participants across the United States. Research is being conducted by 5 organizations including National Institute of Allergy and Infectious Diseases (NIAID), Stanford University, Eli Lilly and Company and 2 others.
2026 Allergies Research Landscape
As of July 2026, the allergies clinical trial landscape includes 5 actively recruiting studies across 14 cities in the United States. These studies are collectively seeking 13,268 participants, with an average enrollment target of 2,654 per study.
The research spans multiple phases of development: 1 study is in PHASE3, 1 study is in PHASE1. The presence of Phase 3 trials indicates that some allergies treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 5 different organizations, including National Institute of Allergy and Infectious Diseases (NIAID), Stanford University, Eli Lilly and Company, University of Colorado, Denver, Mabylon AG.
Geographically, allergies trials are most concentrated in Colorado Springs, Colorado (2 trials); Bethesda, Maryland (1 trial); Palo Alto, California (1 trial); Huntington Beach, California (1 trial); Inglewood, California (1 trial) and 7 other cities.
Featured Allergies Studies
Highlighted recruiting studies for allergies, selected by enrollment size and research scope.
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Background: Allergic or sinus diseases can affect the skin, sinuses, airways, and other parts of the body. Examples include pollen and environmental allergies, food allergies, asthma, and eczema. To learn more about how to prevent and treat these diseases, researchers need to study data, blood, fluid, and tissue samples from people affected by them. Objective: To collect data, blood, fluid, and...
Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
The purpose of this study is to strengthen our ability to accurately diagnose allergies and understand cellular, humoral, genetic components and physiological changes in allergic disease
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to 29.5 months.
Frequently Asked Questions About Allergies Clinical Trials
Are there allergies clinical trials near me?
Yes, there are 5 allergies clinical trials currently recruiting across 14+ cities in the United States, including Colorado Springs, Colorado; Bethesda, Maryland; Palo Alto, California. Browse the studies above to find one at a location convenient for you.
How do I join a allergies clinical trial?
To join a allergies clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are allergies clinical trials free?
Yes, participation in allergies clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of allergies treatments are being studied?
Current allergies clinical trials are testing a range of approaches across PHASE3 (1 study), PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 5 research organizations.
Is it safe to participate in allergies clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov